Deadline: 4 August 2020
The International Society for Infectious Diseases (ISID) and Pfizer Global Medical Grants has announced a new competitive grant challenge to support programs working on antimicrobial stewardship campaigns throughout Africa and the Middle East.
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives to improve patient outcomes in areas of unmet medical need. These areas include research, quality improvement measures, and expanded educational opportunities that align with Pfizer’s medical and scientific strategies.
They are seeking innovative quality improvement health services and/or educational research applications that identify and evaluate practices for successfully implementing key elements of antimicrobial stewardship programs. Programs designed for healthcare organizations, hospitals, tertiary care clinics, and educational settings are all applicable.
Funding Information
Projects can request up to $100,000 USD of funds to support two-year initiatives.
Target Audience
Small and large hospitals, academic medical centers, community hospitals, and ambulatory care settings and other healthcare facilities, e.g. nursing homes.
Eligibility Criteria
- The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations; public health organizations, environmental health organizations, government agencies; Research facilities and other entities with a mission related to healthcare improvement.
- Types of organizations eligible to apply for grants include hospitals, academic medical centers, schools of nursing or pharmacy, professional societies and associations, and other institutions specializing in specific healthcare-related disciplines (e.g., public health, quality improvement).
- Collaborations within institutions (e.g., between departments and/or interprofessional), as well as between different institutions / organizations / associations, are strongly encouraged. Antimicrobial resistance challenges require input from multiple stakeholders where limited resources can be judiciously allocated through collaborative approaches. Please note all partners must have a relevant role and the requesting organization must have a key role in the project. Projects with direct organizing effort and health outcomes focusing on patient populations in Africa and the Middle East will be prioritized for funding consideration.
Criteria
Proposals will be reviewed according to the following critieria:
- Innovation – Does the work address a knowledge gap not yet anwsered in the proposed country or region?.
- Data/knowledge transfer – How can other hospitals/clinics/institutions benefit from the data, methodology and/or results?
- Probability – Is there a high likelihood of generating actionable data within the project period?
- Sustainability – Does the support go primarily to researchers living within the region and the proposed project benefits the regional patient population?
- Patient Safety – Do proposals take into account potential impacts on patient safety and present ways to mitigate potential adverse effects?
For more information, visit https://isid.org/isid-pfizer-grant-program-ams-africa-middle-east/